Serum bone Gla protein and other biochemical estimates of bone turnover in early postmenopausal women during prophylactic treatment for osteoporosis.

Serum bone Gla protein (BGP) and conventional biochemical indices of bone metabolism were determined in 66 early postmenopausal women during a double-blind therapeutic trial performed to investigate the effect of oestrogen, calcium and 1,25 (OH)2D3 on postmenopausal osteoporosis. The biochemical variables were determined before, during and after withdrawal of therapy. We found a very high correlation between serum BGP and serum alkaline phosphatase--a measure of bone formation, less high correlation between serum BGP and the remaining parameters--indices of bone resorption. It is concluded that serum BGP probably reflects bone formation and may prove to be a useful new biochemical marker.

[1]  J. Pødenphant,et al.  An easy and reliable method for determination of urinary hydroxyproline. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[2]  J. Lian,et al.  Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3. , 1983, The Journal of clinical endocrinology and metabolism.

[3]  C. Christiansen,et al.  Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women. , 1982, The Journal of clinical endocrinology and metabolism.

[4]  P. Price,et al.  Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. , 1981, The Journal of biological chemistry.

[5]  P. Price,et al.  1,25-dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone protein. , 1981, Biochemical and biophysical research communications.

[6]  L. Deftos,et al.  New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. , 1980, The Journal of clinical investigation.

[7]  K. Kivirikko,et al.  [Biosynthesis of collagen and its disorders]. , 1979, Duodecim; laaketieteellinen aikakauskirja.

[8]  J. Poser,et al.  Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Kelly,et al.  Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. , 1972, The American journal of medicine.

[10]  C. Christiansen,et al.  Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females , 1971, European journal of clinical investigation.

[11]  M. Kleerekoper,et al.  Alkaline Phosphatase and Metabolic Bone Disorders , 1977 .